The Oncology Institute, Inc. TOI Long-Term Debt
Long-Term Debt at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s long-term debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s long-term debt?
- The Oncology Institute, Inc. (TOI) reported long-term debt of $78.61M in Q1 2026.
- How has The Oncology Institute, Inc.'s long-term debt changed year-over-year?
- The Oncology Institute, Inc.'s long-term debt increased by 6.4% year-over-year, from $73.89M to $78.61M.
- What is the long-term trend for The Oncology Institute, Inc.'s long-term debt?
- Over 5 years (2020 to 2025), The Oncology Institute, Inc.'s long-term debt has grown at a 63.8% compound annual growth rate (CAGR), from $6.56M to $77.4M.
- What does long-term debt mean?
- Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.